5,899 trials (keyword fallback)
Pulmonary Disease, Chronic Obstructive
Primary: Number of Participants With the Indicated Device Preference Based on the Size of the Numbers on the Dose Counter — 107; 86; 23; 34 participants — p=<0.001
Contraception
Primary: 6 Month Pregnancy Probabilities With Typical Use — 0.5; 1.4; 4.0 percentage of probability
Type II Diabetes
Primary: Patient Medication Preference as Estimated by a Choice Model — 0.983; 0.362; 0.284; 0.261 utility of
Type II Diabetes
Primary: Priority Scores for Potential Barriers and Facilitators for Diabetes Self-management — 0.505; 0.327; 0.500; 0.369 units on a scale
Rhinitis, Allergic, Perennial
Primary: Correlations of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) Preference Module With Treatment Satisfaction Questionnaire for Medicines (TSQM)…
Carcinoma, Renal Cell
Primary: Number of Participants With Preference for Pazopanib Versus Sunitinib as Assessed by the Patient Preference Questionnaire (PPQ) — 19; 6; 37; 43 participants — p=<0.001
Rhinitis, Allergic, Perennial and Seasonal
Primary: Number of Participants With Overall Preference for Nasal Spray Assessed by Preference Questionnaire. — 96; 59; 30; 57 Participants — p=<0.001
Women's Health · HIV Infection · Genital Diseases, Female
Primary: CD4+ to CD8+ T Cell Ratio in Cervical Biopsies — 0.46; 0.52 Cervical CD4+:CD8+ T cell ratio — p=0.6
Perennial Allergic Rhinitis
Primary: Total Preference Composite Score Assessed at the End of the Study. The Total Preference Score is the Standardized Sum of 17 Individual Preference Items — 68.3 scores on…
Parkinson's Disease
Primary: Number of Participants With Adverse Events — 2; 2; 2; 1 participants
ACL Injury
Primary: Number of Participants With Decrease in Knee Valgus Measurement — 307; 216 Participants
Barrett Esophagus · GERD
Primary: 7 Days Post-EGD Impact of Events Score (IES) — 1.42; 1.21; 0 units on a scale
Transfusion-dependent Thalassemia · Non-transfusion-dependent Thalassemia
Primary: Number of Participants Preferring Deferasirox FCT or DT at Week 48 Based on Preference Questionnaire (Item 2) — 10; 121; 3 Participants — p=<.0001
Pulmonary Disease, Chronic Obstructive
Primary: Total Mean Score of the Validated Patient Satisfaction and Preference Questionnaire (PASAPQ) — 80.71; 79.92 units on a scale
Orthodontic Patient Experience
Primary: Orthodontic Patient Comfort — 9.2; 7.7 score on a scale — p=0.0006